Skeletal Muscle Protein Tyrosine Phosphatase 1B Regulates Insulin Sensitivity in African Americans

Protein tyrosine phosphatase 1B (PTP1B) is postulated to modulate insulin action by dephosphorylating the insulin receptor signaling proteins and attenuating insulin signaling. We sought to determine the relationship of skeletal muscle PTP1B to whole-body insulin sensitivity. We studied 17 African Americans with type 2 diabetes mellitus (T2DM) and 16 without diabetes. PTP1B gene expression and protein abundance were determined in the biopsied skeletal muscles at the baseline of a hyperinsulinemic-euglycemic clamp. PTP1B gene expression was significantly higher in subjects with T2DM versus control (P < 0.0001) and remained significantly different after adjusting for age and insulin sensitivity (P = 0.05). PTP1B gene expression was positively related to protein abundance (rs = 0.39; P = 0.03; adjusted for age and insulin sensitivity) and negatively related to insulin sensitivity (rs = −0.52; P = 0.002; adjusted for age). Overexpression and interference RNA of PTP1B were performed in primary human skeletal muscle culture. PTP1B overexpression resulted in reduction of Akt phosphorylation in the control subjects. Moreover, interference RNA transfection downregulated PTP1B expression and enhanced Akt phosphorylation in subjects with T2DM. These data show that skeletal muscle PTP1B gene expression is increased in African American subjects with T2DM, is negatively associated with whole-body insulin sensitivity, and contributes to modulation of insulin signaling.

[1]  B. Larijani,et al.  Palmitate Enhances Protein Tyrosine Phosphatase 1B (PTP1B) Gene Expression at Transcriptional Level in C2C12 Skeletal Muscle Cells , 2011, Inflammation.

[2]  W. Johnson,et al.  The contribution of race and diabetes status to metabolic flexibility in humans. , 2010, Metabolism: Clinical and Experimental.

[3]  B. Larijani,et al.  Palmitate and inflammatory state additively induce the expression of PTP1B in muscle cells. , 2010, Biochemical and biophysical research communications.

[4]  C. Drevon,et al.  IL-7 is expressed and secreted by human skeletal muscle cells. , 2010, American journal of physiology. Cell physiology.

[5]  B. Larijani,et al.  Protein Tyrosine Phosphatase-1B (PTP-1B) Knockdown Improves Palmitate-Induced Insulin Resistance in C2C12 Skeletal Muscle Cells , 2010, Lipids.

[6]  B. Balkau,et al.  Functional polymorphism of the NFKB1 gene promoter is related to the risk of dilated cardiomyopathy , 2009, BMC Medical Genetics.

[7]  B. Monia,et al.  Inhibition of protein tyrosine phosphatase-1B with antisense oligonucleotides improves insulin sensitivity and increases adiponectin concentrations in monkeys. , 2009, Endocrinology.

[8]  W. Cefalu,et al.  Modulation of Skeletal Muscle Insulin Signaling With Chronic Caloric Restriction in Cynomolgus Monkeys , 2009, Diabetes.

[9]  I. Raskin,et al.  Bioactives of Artemisia dracunculus L enhance cellular insulin signaling in primary human skeletal muscle culture. , 2008, Metabolism: Clinical and Experimental.

[10]  B. Neel,et al.  Protein-tyrosine Phosphatase 1B Expression Is Induced by Inflammation in Vivo* , 2008, Journal of Biological Chemistry.

[11]  R. Hegele,et al.  Polymorphisms within the protein tyrosine phosphatase 1B (PTPN1) gene promoter: functional characterization and association with type 2 diabetes and related metabolic traits. , 2007, Clinical chemistry.

[12]  C. Kahn,et al.  Protein-tyrosine Phosphatase 1B Deficiency Reduces Insulin Resistance and the Diabetic Phenotype in Mice with Polygenic Insulin Resistance* , 2007, Journal of Biological Chemistry.

[13]  C. Bogardus,et al.  Protein tyrosine phosphatase 1B is not a major susceptibility gene for type 2 diabetes mellitus or obesity among Pima Indians , 2007, Diabetologia.

[14]  W. Cefalu,et al.  Chromium picolinate enhances skeletal muscle cellular insulin signaling in vivo in obese, insulin-resistant JCR:LA-cp rats. , 2006, The Journal of nutrition.

[15]  T. Spector,et al.  Protein tyrosine phosphatase-1B gene PTPN1: selection of tagging single nucleotide polymorphisms and association with body fat, insulin sensitivity, and the metabolic syndrome in a normal female population. , 2005, Diabetes.

[16]  Yong Wu,et al.  Rosiglitazone ameliorates abnormal expression and activity of protein tyrosine phosphatase 1B in the skeletal muscle of fat‐fed, streptozotocin‐treated diabetic rats , 2005, British journal of pharmacology.

[17]  M. Daly,et al.  Association testing of the protein tyrosine phosphatase 1B gene (PTPN1) with type 2 diabetes in 7,883 people. , 2005, Diabetes.

[18]  Nicholette D. Palmer,et al.  Association of protein tyrosine phosphatase 1B gene polymorphisms with type 2 diabetes. , 2004, Diabetes.

[19]  Nicholette D. Palmer,et al.  Association of protein tyrosine phosphatase 1B gene polymorphisms with measures of glucose homeostasis in Hispanic Americans: the insulin resistance atherosclerosis study (IRAS) family study. , 2004, Diabetes.

[20]  V. Thorsson,et al.  Integrated Genomic and Proteomic Analyses of Gene Expression in Mammalian Cells*S , 2004, Molecular & Cellular Proteomics.

[21]  G. Shulman,et al.  Transgenic Overexpression of Protein-tyrosine Phosphatase 1B in Muscle Causes Insulin Resistance, but Overexpression with Leukocyte Antigen-related Phosphatase Does Not Additively Impair Insulin Action* , 2004, Journal of Biological Chemistry.

[22]  J. Carvalheira,et al.  Modulation of IR/PTP1B interaction and downstream signaling in insulin sensitive tissues of MSG-rats. , 2003, Life sciences.

[23]  P. Almgren,et al.  A variation in 3' UTR of hPTP1B increases specific gene expression and associates with insulin resistance. , 2002, American journal of human genetics.

[24]  M. Quon,et al.  Tyr612 and Tyr632 in Human Insulin Receptor Substrate-1 Are Important for Full Activation of Insulin-Stimulated Phosphatidylinositol 3-Kinase Activity and Translocation of GLUT4 in Adipose Cells. , 2001, Endocrinology.

[25]  D. Barford,et al.  Molecular basis for the dephosphorylation of the activation segment of the insulin receptor by protein tyrosine phosphatase 1B. , 2000, Molecular cell.

[26]  N. Begum,et al.  Elevated expression and activity of protein-tyrosine phosphatase 1B in skeletal muscle of insulin-resistant type II diabetic Goto-Kakizaki rats. , 2000, Biochemical and biophysical research communications.

[27]  M. White,et al.  Tyrosine Dephosphorylation and Deactivation of Insulin Receptor Substrate-1 by Protein-tyrosine Phosphatase 1B , 2000, The Journal of Biological Chemistry.

[28]  D. Bandyopadhyay,et al.  Marked impairment of protein tyrosine phosphatase 1B activity in adipose tissue of obese subjects with and without type 2 diabetes mellitus. , 1999, The Journal of laboratory and clinical medicine.

[29]  B. Kennedy,et al.  Increased insulin sensitivity and obesity resistance in mice lacking the protein tyrosine phosphatase-1B gene. , 1999, Science.

[30]  M. Quon,et al.  Physiological role of Akt in insulin-stimulated translocation of GLUT4 in transfected rat adipose cells. , 1997, Molecular endocrinology.

[31]  G. Dohm,et al.  Alterations in skeletal muscle protein-tyrosine phosphatase activity and expression in insulin-resistant human obesity and diabetes. , 1997, The Journal of clinical investigation.

[32]  J. Chernoff,et al.  Protein-Tyrosine Phosphatase 1B Complexes with the Insulin Receptor in Vivo and Is Tyrosine-phosphorylated in the Presence of Insulin* , 1997, The Journal of Biological Chemistry.

[33]  M. Birnbaum,et al.  Expression of a Constitutively Active Akt Ser/Thr Kinase in 3T3-L1 Adipocytes Stimulates Glucose Uptake and Glucose Transporter 4 Translocation* , 1996, The Journal of Biological Chemistry.

[34]  H. Beck-Nielsen,et al.  Altered basal and insulin-stimulated phosphotyrosine phosphatase (PTPase) activity in skeletal muscle from NIDDM patients compared with control subjects , 1996, Diabetologia.

[35]  Jerrold M. Olefsky,et al.  Protein-tyrosine Phosphatase 1B Is a Negative Regulator of Insulin- and Insulin-like Growth Factor-I-stimulated Signaling* , 1996, The Journal of Biological Chemistry.

[36]  S. Haffner,et al.  The Insulin Resistance Syndrome Revisited , 1996, Diabetes Care.

[37]  B. Goldstein,et al.  Increased abundance of the receptor-type protein-tyrosine phosphatase LAR accounts for the elevated insulin receptor dephosphorylating activity in adipose tissue of obese human subjects. , 1995, The Journal of clinical investigation.

[38]  B. Goldstein,et al.  Alterations in specific protein-tyrosine phosphatases accompany insulin resistance of streptozotocin diabetes. , 1995, The American journal of physiology.

[39]  R. Henry,et al.  Skeletal muscle protein tyrosine phosphatase activity and tyrosine phosphatase 1B protein content are associated with insulin action and resistance. , 1994, The Journal of clinical investigation.

[40]  C. Kahn,et al.  The insulin signaling system. , 1994, The Journal of biological chemistry.

[41]  R. DeFronzo.  Insulin Resistance, Hyperinsulinemia, and Coronary Artery Disease: A Complex Metabolic Web , 1992, Journal of cardiovascular pharmacology.

[42]  C. Bogardus,et al.  Abnormal Regulation of Protein Tyrosine Phosphatase Activities in Skeletal Muscle of Insulin-Resistant Humans , 1991, Diabetes.

[43]  G. Reaven.  Banting lecture 1988. Role of insulin resistance in human disease. , 1988, Diabetes.

[44]  A. Baron,et al.  Rates and tissue sites of non-insulin- and insulin-mediated glucose uptake in humans. , 1988, The American journal of physiology.

[45]  G. Reaven.  Role of Insulin Resistance in Human Disease , 1988, Diabetes.

[46]  R. DeFronzo,et al.  Glucose clamp technique: a method for quantifying insulin secretion and resistance. , 1979, The American journal of physiology.

[47]  T. Church,et al.  Skeletal muscle NAMPT is induced by exercise in humans. , 2010, American journal of physiology. Endocrinology and metabolism.

[48]  J. Leahy.  Prevalence of Diabetes and Impaired Fasting Glucose in Adults in the U.S. Population: National Health and Nutrition Examination Survey 1999–2002 , 2007 .

[49]  M. Quon,et al.  Tyr(612) and Tyr(632) in human insulin receptor substrate-1 are important for full activation of insulin-stimulated phosphatidylinositol 3-kinase activity and translocation of GLUT4 in adipose cells. , 2001, Endocrinology.

[50]  G. Reaven.  Banting lecture 1988 , 1997 .